saphnelo
astrazeneca ab - anifrolumab - lupus erythematosus, systemisk - immunosuppressiva - saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (sle), despite standard therapy.
ceprotin
takeda manufacturing austria ag - humant protein c - purpura fulminans; protein c deficiency - antitrombotiske midler - ceprotin is indicated for prophylaxis and treatment of purpura fulminans coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.
regranex
janssen-cilag international nv - becaplermin - wound healing; skin ulcer - præparater til behandling af sår og sår - regranex angives i forening med andre gode sår pleje foranstaltninger, at fremme granulering og dermed heling af fuld-tykkelse, neuropatiske, kronisk, diabetisk sår mindre end eller lig til 5 cm2.
danadim progress emulsionskoncentrat
fmc agricultural solutions a/s (tidligere: cheminova a/s) - dimethoat - emulsionskoncentrat - 400 g/l dimethoat
adtralza
leo pharma a/s - tralokinumab - dermatitis, atopisk - andre dermatologiske præparater - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.
spongostan spugna di gelatina emostatica riassorbibile
spongostan spugna di gelatina emostatica riassorbibile
spongostan polvere di gelatina emostatica riassorbibile